Skip to main content
Clinical Trials/NCT05562414
NCT05562414
Recruiting
Not Applicable

Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis: A Pilot Study.

Klinik Valens1 site in 1 country30 target enrollmentOctober 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis, Chronic Progressive
Sponsor
Klinik Valens
Enrollment
30
Locations
1
Primary Endpoint
Functional mobility
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Endurance training is a cornerstone of rehabilitation in Multiple Sclerosis (MS) due to its beneficial effects on multiple MS-related symptoms, such as health-related quality of life, aerobic capacity (VO2peak), functional mobility, gait, depressive symptoms, and fatigue.

Persons with progressive phenotypes of MS, namely primary progressive MS (PPMS) and secondary progressive (SPMS), represent a minor proportion of the total MS population, thus having been underrepresented in previous studies. The generalizability of existing evidence may be compromised by differences in symptom expression between MS phenotypes, with a dominance of motor symptoms (i.e., paraspasticity and/or paraparesis) in PPMS and SPMS.

Adding up to this, clinical experiences of neurologists and sports scientists reveal that the effects of endurance exercise are characterized by a distinct time course, firstly inducing a minor and transient deterioration of motor symptoms that is followed by motor symptom alleviation beyond baseline level. This phenomenon was mainly related to the performance of High-Intensity Interval training (HIIT), but not to moderate-intensity continuous training (MCT).

Therefore, this pilot study aims to systematically investigate the time course of acute motor effects on spasticity, functional mobility, gait, and dexterity in persons with PPMS and SPMS following two different endurance training protocols, that are HIIT and MCT.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
April 1, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Klinik Valens
Responsible Party
Principal Investigator
Principal Investigator

Jens Bansi

Dr. Jens Bansi, Head of Research and Development

Klinik Valens

Eligibility Criteria

Inclusion Criteria

  • adult age (≥ 18 years)
  • definite MS diagnosis according the 2017 revised McDonald criteria
  • PPMS/SPMS phenotype according to the 2013 revised Lublin criteria
  • Expanded Disability Status Scale (EDSS) score ≤ 6.0
  • Informed Consent as documented by signature of participants and PI

Exclusion Criteria

  • severe lower extremity spasticity or severe concomitant disease states (i.e., orthopaedic, cardiovascular, metabolic, psychiatric (e.g., substance abuse), other neurological, other serious medical conditions) impairing the ability to participate
  • inability to follow study procedures (e.g., due to language barriers)
  • suspected non-compliance
  • previous enrolment into the current study
  • enrolment of the investigator, his/her family members, employees, and other dependent persons

Outcomes

Primary Outcomes

Functional mobility

Time Frame: Change from baseline to directly after, 1-hour after, 3-hours after, and 5-hours after the exercise bout

Functional mobility is assessed by the Timed-Up-and-Go Test (TUG). For the TUG, participants are asked to get up from a chair, walk a 3 metres distance, perform a 180° turn, return to the chair, and sit down again as fast as possible. Assessment takes place on a single day, before (T0), 5 minutes after (T1), 60 minutes after (T2), 180 minutes after (T3), 300 minutes (T4) after HIIT/MCT cycling bout.

Secondary Outcomes

  • Spasticity (subjective)(Change from baseline to directly after, 1-hour after, 3-hours after, and 5-hours after the exercise bout)
  • Gait pattern(Change from baseline to directly after, 1-hour after, 3-hours after and 5-hours after the exercise bout)
  • Dexterity(Change from baseline to directly after, 1-hour after, 3-hours after, and 5-hours after the exercise bout)
  • Spasticity (objective)(Change from baseline to directly after, 1-hour after, 3-hours after, and 5-hours after the exercise bout)

Study Sites (1)

Loading locations...

Similar Trials